Does mobilization for autologous stem cell transplantation damage stromal layer formation?


Autoria(s): SCHIMIEGUEL, Dulce Marta; DOMINATO, Juliana Augusta Albieri; ZATTAR, Karin Cecyn; SILVA, Maria Regina Regis; SOUZA, Marlon Knabben de; NADER, Helena Bonciani; BORELLI, Primavera; OLIVEIRA, Jose Salvador Rodrigues de
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

Autologous hematopoietic stem cell transplantation (HSCT) has proved efficient to treat hematological malignancies. However, some patients fail to mobilize HSCs. It is known that the microenvironment may undergo damage after allogeneic HSCT. However little is known about how chemotherapy and growth factors contribute to this damage. We studied the stromal layer formation(SLF) and velocity before and after HSC mobilization, through long-term bone marrow culture from 22 patients and 10 healthy donors. Patients` SLF was similar at pre- (12/22)and post-mobilization (9/20), however for controls this occurred more at pre- mobilization (9/10; p=0.03). SLF velocity was higher at pre than post-mobilization in both groups. Leukemias and multiple myeloma showed faster growth of SLF than lymphomas at post-mobilization, the latter being similar to controls. These findings could be explained by less uncommitted HSC in controls than patients at post-mobilization. Control HSCs may migrate more in response to mobilization, resulting in a reduced population by those cells.

FAPESP[02/0999-4]

FAPESP[02/010290-1]

Identificador

HEMATOLOGY, v.14, n.2, p.76-83, 2009

1024-5332

http://producao.usp.br/handle/BDPI/19626

10.1179/102453309X385232

http://dx.doi.org/10.1179/102453309X385232

Idioma(s)

eng

Publicador

MANEY PUBLISHING

Relação

Hematology

Direitos

closedAccess

Copyright MANEY PUBLISHING

Palavras-Chave #Autologous stem cell transplantation #long-term bone marrow culture #mobilization #hematopoiesis #ACUTE MYELOID-LEUKEMIA #LONG-TERM CULTURE #BONE-MARROW-TRANSPLANTATION #HEMATOPOIETIC STEM #MULTIPLE-MYELOMA #EXTRACELLULAR-MATRIX #CHOP CHEMOTHERAPY #RANDOMIZED-TRIAL #PROGENITOR CELLS #ELDERLY-PATIENTS #Hematology
Tipo

article

original article

publishedVersion